Get started
Author

Aleksandar Tepavac

Observed names: A Tepavac, A. Tepavac, AleksandarP Tepavac
OpenAlex ID: A5111906282
Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC).
2013 · Bojan Zaric, Vladimir Stojsic, et al. · Europe PMC (PubMed Central) · 34
Clinical Characteristics, Tumor, Node, Metastasis Status, and Mutation Rate in Domain of Epidermal Growth Factor Receptor Gene in Serbian Patients with Lung Adenocarcinoma
2014 · Bojan Zaric, Vladimir Stojsic, et al. · Journal of Thoracic Oncology · 19
Paraneoplastic dermatomyositis associated with adenocarcinoma of the lung
2014 · DaliborkaS Bursac, DanicaS Sazdanic-Velikic, et al. · Journal of Cancer Research and Therapeutics · 9
Successful treatment of Pseudomembranous necrotizing Aspergillus tracheobronchitis in a patient with acute myeloid leukemia
2014 · Jelena Stanic, Zivka Eri, et al. · Srpski arhiv za celokupno lekarstvo · 2
PDF
Atelectasis: positive or negative prognostic factor on outcome of patients with non-small cell lung cancer?
2010 · A Tepavac, N Secen, et al. · PubMed · 2
Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer
2011 · Daliborka Bursac, Nevena Secen, et al. · European Respiratory Journal · 1
EP.13D.10 Breast Metastases from Small Cell Lung Carcinoma
2024 · J.I. Mikov, G. Stojanović, et al. · Journal of Thoracic Oncology
PDF
Kardiotoksičnost hemioterapije prve linije(gemcitabin/cisplatin i paclitaxel/carboplatin) kod bolesnika sa uznapredovalim stadijumom nemikrocelulrnog karcinoam bronha
2017 · Institut za plućne bolesti Vojvodine, Klinika za pulmološku onkologiju,Sremska Kamenica, Srbija, Daliborka Bursać, et al. · Respiratio
PDF
PUB069 The Prognostic Significance of Thrombocytopenia during Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
2017 · Aleksandar Tepavac, Danica Sazdanic Velikic, et al. · Journal of Thoracic Oncology
P2.03a-042 Comorbidity as a Prognostic Factor in Elderly Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
2017 · Danica Sazdanic-Velikic, Aleksandar Tepavac, et al. · Journal of Thoracic Oncology
PDF
Cardiotoxic effects of gemcitabin/cisplatin vs paclitaxel/carboplatin first-line chemotherapy in patients with advanced non-small cell lung cancer
2016 · D.S. Bursac, T. Sarcev, et al. · Annals of Oncology
PDF
The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
2016 · Aleksandar Tepavac, Daliborka Bursac, et al. · European Respiratory Journal
Prognostički značaj mijelotoksičnosti u toku hemioterapije za preživljavanje bolesnika sa uznapredovalim nemikrocelularnim karcinomom bronha
2015 · Aleksandar Tepavac · National Repository of Dissertations in Serbia
Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection
2013 · Tatjana Sarcev, Slobodanka Pena-Karan, et al. · European Respiratory Journal
4p Clinico-pathological Characteristics of Patients With Lung Adenocarcinoma Harbouring Mutations in the Epidermal Growth Factor Receptor (egfr) Gene in the Serbian Population
2013 · B. Zaric, V. Stojsic, et al. · Lung Cancer
AB 96. Chemotherapy for lung cancer.
2012 · Nevena Sečen, Daliborka Bursać, et al. · PubMed Central
Characteristics of 982 Lung Cancer Patients in Serbia According to the WHO/IASLC Classification of Lung Cancers and Subsequent Treatment – Avatar Epidemiology Study
2012 · D. Jovanovic, N. Secen, et al. · Annals of Oncology
PDF
Hematological toxicity associated with gemcitabine/cisplatin in elderly non-small cell lung cancer patients
2011 · Nevena Secen, Danica Sazdanic-Velikic, et al. · European Respiratory Journal
Works count: 18
Citation count: 67
H-index: 3
I10-index: 2
Year
Topic
Type